A Study of DM002 in Patients With Advanced Solid Tumors

Clinical trial NCT06751329 · RECRUITING

Trial details

NCT number: NCT06751329
Sponsor: Xadcera Biopharmaceutical (Suzhou) Co., Ltd.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Ovarian Neoplasms Prostatic Neoplasms Endometrial Neoplasms Colorectal Neoplasms Solid Carcinoma Pancreatic Cancer

Start date: 2025-02-17
Primary completion: 2027-10-08
Enrollment: 280

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.